These 4 Measures Indicate That Dishman Carbogen Amcis (NSE:DCAL) Is Using Debt In A Risky Way
Jan 16
Have your own idea? Try our Stock Screener
Indian (NIFTY) Clinical Research and Equipment Industry Analysis
UpdatedFeb 01, 2025
DataAggregated Company Financials
Companies18
- 7D-3.6%
- 3M-7.1%
- 1Y38.7%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 4.0%, driven by Divi's Laboratories declining 3.2%. Meanwhile, Suven Life Sciences actually outperformed within the industry, gaining 6.3% in the last week. In the past year, the industry has gained 43%. Looking forward, earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 01 Feb 2025 | ₹2.4t | ₹270.9b | ₹30.5b | 48.7x | 77.2x | 8.7x |
| Mon, 30 Dec 2024 | ₹2.5t | ₹269.1b | ₹30.1b | 51.8x | 83.9x | 9.4x |
| Wed, 27 Nov 2024 | ₹2.4t | ₹254.2b | ₹28.8b | 50.4x | 84.8x | 9.6x |
| Fri, 25 Oct 2024 | ₹2.3t | ₹247.4b | ₹26.2b | 51.1x | 89.7x | 9.5x |
| Sun, 22 Sep 2024 | ₹2.3t | ₹247.6b | ₹26.3b | 49.7x | 87.3x | 9.3x |
| Tue, 20 Aug 2024 | ₹1.9t | ₹205.3b | ₹23.8b | 37.9x | 78.9x | 9.2x |
| Thu, 18 Jul 2024 | ₹1.8t | ₹202.0b | ₹23.9b | 37.9x | 75.5x | 8.9x |
| Sat, 15 Jun 2024 | ₹1.8t | ₹194.5b | ₹21.5b | 34.3x | 82.1x | 9.1x |
| Mon, 13 May 2024 | ₹1.5t | ₹194.1b | ₹21.6b | 31.7x | 69.9x | 7.8x |
| Wed, 10 Apr 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 28.7x | 77.5x | 8.6x |
| Fri, 08 Mar 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 31.1x | 73x | 8.1x |
| Sun, 04 Feb 2024 | ₹1.4t | ₹166.6b | ₹19.0b | 32.6x | 74.7x | 8.5x |
| Tue, 02 Jan 2024 | ₹1.4t | ₹155.9b | ₹18.1b | 21.7x | 78.7x | 9.1x |
| Thu, 30 Nov 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 22.3x | 76.4x | 8.9x |
| Sat, 28 Oct 2023 | ₹1.3t | ₹156.1b | ₹19.8b | 23x | 63.5x | 8.1x |
| Mon, 25 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 24.6x | 70.4x | 9x |
| Wed, 23 Aug 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 26.9x | 70.5x | 9x |
| Fri, 21 Jul 2023 | ₹1.4t | ₹156.5b | ₹23.0b | 30.1x | 59.7x | 8.8x |
| Sun, 18 Jun 2023 | ₹1.3t | ₹157.2b | ₹23.0b | 28.3x | 57.7x | 8.5x |
| Tue, 16 May 2023 | ₹1.2t | ₹163.0b | ₹28.6b | 33.3x | 42.9x | 7.5x |
| Thu, 13 Apr 2023 | ₹1.2t | ₹159.5b | ₹28.4b | 34x | 41.6x | 7.4x |
| Sat, 11 Mar 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 30.9x | 37.1x | 6.6x |
| Mon, 06 Feb 2023 | ₹1.1t | ₹158.6b | ₹28.4b | 31.9x | 37.7x | 6.8x |
| Wed, 04 Jan 2023 | ₹1.2t | ₹164.9b | ₹34.5b | 30.9x | 35.4x | 7.4x |
| Fri, 02 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 30.2x | 35.8x | 7.5x |
| Sun, 30 Oct 2022 | ₹1.3t | ₹164.1b | ₹36.1b | 36.8x | 35.2x | 7.7x |
| Tue, 27 Sep 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 36.3x | 35.8x | 7.9x |
| Thu, 25 Aug 2022 | ₹1.3t | ₹162.6b | ₹35.8b | 36.2x | 35.3x | 7.8x |
| Sat, 23 Jul 2022 | ₹1.3t | ₹158.8b | ₹34.2b | 34x | 39.2x | 8.4x |
| Mon, 20 Jun 2022 | ₹1.2t | ₹158.3b | ₹34.2b | 31.2x | 35.6x | 7.7x |
| Wed, 18 May 2022 | ₹1.4t | ₹147.3b | ₹29.8b | 40.4x | 48.6x | 9.8x |
| Fri, 15 Apr 2022 | ₹1.6t | ₹148.3b | ₹29.4b | 38.2x | 52.8x | 10.5x |
| Sun, 13 Mar 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 35.8x | 50.6x | 10x |
| Tue, 08 Feb 2022 | ₹1.5t | ₹139.5b | ₹25.0b | 38.2x | 58.1x | 10.4x |
Price to Earnings Ratio
58.1x
Current Industry PE
- Investors are optimistic on the Indian Life Sciences Tools and Services industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 78.9x which is higher than its 3-year average PE of 60.1x.
- The industry is trading close to its 3-year average PS ratio of 8.5x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have grown 6.6% per year over the last three years.
- Revenues for these companies have grown 25% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Clinical Research and Equipment compare with similar industries?
| IN Market | 0.93% | |
| Healthcare | -1.26% | |
| Life Sciences | -3.57% | |
| Clinical Research and Equipment | -3.57% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 530239 Suven Life Sciences | ₹128.75 | 6.3% +₹1.7b | 18.5% | PS370.7x | |
| INNOVACAP Innova Captab | ₹1.00k | 0.2% +₹105.9m | 88.3% | PE48.6x | |
| 544184 Borosil Scientific | ₹158.35 | 0.2% +₹22.2m | n/a | PE48.8x | |
| 538837 Jeevan Scientific Technology | ₹45.30 | 0.5% +₹3.6m | -24.0% | PE603.3x |